Creating shared value as a new business model for pharmaceutical companies " Glaxo Smith Kline (GSK) MODEL "

Abstract

This paper aims to provide shared value as a new business model for pharmaceutical companies to create social and economic value. Based on the dedicative approach we analysed Glaxo smith kline programs that created shared value, we provide new way of doing business for pharmaceutical companies.